Literature DB >> 21529281

Regeneration of completely transected spinal cord using scaffold of poly(D,L-lactide-co-glycolide)/small intestinal submucosa seeded with rat bone marrow stem cells.

Kkot Nim Kang1, Ju Young Lee, Da Yeon Kim, Bit Na Lee, Hyun Hee Ahn, Bong Lee, Gilson Khang, So Ra Park, Byoung Hyun Min, Jae Ho Kim, Hai Bang Lee, Moon Suk Kim.   

Abstract

Using a complete spinal cord transection model, the present study employed a combinatorial strategy comprising rat bone marrow stem cells (rBMSCs) and polymer scaffolds to regenerate neurological function after spinal cord injury (SCI) of different lengths. SCI models with completely transected lesions were prepared by surgical removal of 1 mm (SC1) or 3 mm (SC3) lengths of spinal cord in the eighth-to-ninth spinal vertebrae, a procedure that resulted in bilateral hindlimb paralysis. A cylindrical poly(D,L-lactide-co-glycolide)/small intestinal submucosa scaffold 1 or 3 mm in length with or without rBMSCs was fitted into the completely transected lesion. Rats in SC1 and SC3 groups implanted with rBMSC-containing scaffolds received Basso-Beattie-Bresnahan scores for hindlimb locomotion of 15 and 8, respectively, compared with ∼3 for control rats in SC1-C and SC3-C groups implanted with scaffolds lacking rBMSCs. The amplitude of motor-evoked potentials recorded in the hindlimb area of the sensorimotor cortex after stimulation of the injured spinal cord averaged ∼100 μV in SC1-C and 10-50 μV in SC3-C groups at 4 weeks, and then declined to nearly zero at 8 weeks. In contrast, the amplitude of motor-evoked potentials increased from ∼300 to 350 μV between 4 and 8 weeks in SC1 rats and from ∼200 to ∼250 μV in SC3 rats. These results demonstrate functional recovery in rBMSC-transplanted rats, especially those with smaller defects. Immunohistochemically stained sections of the injury site showed clear evidence for axonal regeneration only in rBMSC-transplanted SC1 and SC3 models. In addition, rBMSCs were detected at the implanted site 4 and 8 weeks after transplantation, indicating cell survival in SCI. Collectively, our results indicate that therapeutic rBMSCs in a poly(D,L-lactide-co-glycolide)/small intestinal submucosa scaffold induced nerve regeneration in a complete spinal cord transection model and showed that functional recovery further depended on defect length.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21529281     DOI: 10.1089/ten.TEA.2011.0122

Source DB:  PubMed          Journal:  Tissue Eng Part A        ISSN: 1937-3341            Impact factor:   3.845


  19 in total

Review 1.  Leveraging "raw materials" as building blocks and bioactive signals in regenerative medicine.

Authors:  Amanda N Renth; Michael S Detamore
Journal:  Tissue Eng Part B Rev       Date:  2012-05-21       Impact factor: 6.389

Review 2.  Stem cells for spine surgery.

Authors:  Joshua Schroeder; Janina Kueper; Kaplan Leon; Meir Liebergall
Journal:  World J Stem Cells       Date:  2015-01-26       Impact factor: 5.326

3.  Experimental and computational analysis of cellular interactions with nylon-3-bearing substrates.

Authors:  Runhui Liu; Kang Z Vang; Pamela K Kreeger; Samuel H Gellman; Kristyn S Masters
Journal:  J Biomed Mater Res A       Date:  2012-05-24       Impact factor: 4.396

Review 4.  Perspectives on tissue-engineered nerve regeneration for the treatment of spinal cord injury.

Authors:  Moon Suk Kim; Hai Bang Lee
Journal:  Tissue Eng Part A       Date:  2014-03-27       Impact factor: 3.845

5.  Comparison of morphology and biocompatibility of acellular nerve scaffolds processed by different chemical methods.

Authors:  Songtao Gao; Yan Zheng; Qiqing Cai; Weitao Yao; Jiaqiang Wang; Peng Zhang; Xin Wang
Journal:  J Mater Sci Mater Med       Date:  2014-01-23       Impact factor: 3.896

6.  Evaluation of small intestine submucosa and poly(caprolactone-co-lactide) conduits for peripheral nerve regeneration.

Authors:  Sun Woo Shim; Doo Yeon Kwon; Bit Na Lee; Jin Seon Kwon; Ji Hoon Park; Jun Hee Lee; Jae Ho Kim; Il Woo Lee; Jung-Woog Shin; Hai Bang Lee; Wan-Doo Kim; Moon Suk Kim
Journal:  Tissue Eng Part A       Date:  2015-01-08       Impact factor: 3.845

Review 7.  Mesenchymal stem cells in the treatment of spinal cord injuries: A review.

Authors:  Venkata Ramesh Dasari; Krishna Kumar Veeravalli; Dzung H Dinh
Journal:  World J Stem Cells       Date:  2014-04-26       Impact factor: 5.326

8.  Current stem cell treatments for spinal cord injury.

Authors:  R Vawda; J Wilcox; Mg Fehlings
Journal:  Indian J Orthop       Date:  2012-01       Impact factor: 1.251

Review 9.  Hydrogels and Cell Based Therapies in Spinal Cord Injury Regeneration.

Authors:  Rita C Assunção-Silva; Eduardo D Gomes; Nuno Sousa; Nuno A Silva; António J Salgado
Journal:  Stem Cells Int       Date:  2015-06-01       Impact factor: 5.443

10.  Tissue engineering is a promising method for the repair of spinal cord injuries (Review).

Authors:  Wenchen Ji; Shouye Hu; Jiao Zhou; Gang Wang; Kunzheng Wang; Yuelin Zhang
Journal:  Exp Ther Med       Date:  2013-12-18       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.